An order signed on June 15, 2010 by Justice Sandra Moss, has paved the way for the settlement of of hundreds of Paxil birth defect cases pending against drug maker GlaxSmithKline, GSK. No Paxil birth defect cases have been tried since the October 13, 2009, verdict where a jury awarded $2.5M to the family of Lyam Kilker, a child born with a congenital heart defect caused by Paxil use during pregnancy. No further trials were commenced, though scheduled since then. The order signed by the Court confirms that these cases all alleging heart birth defects caused by exposure to Paxil during pregnancy, were settled by GSK.

Since Paxil came on the market in 1992, GSK has faced three significant litigations. GSK has reportedly paid out close to $1 billion to resolve Paxil lawsuits to date. These reported settlements will add significantly to that total.